tiprankstipranks
Trending News
More News >
Sunshine Biopharma, Inc. (SBFM)
:SBFM
US Market

Sunshine Biopharma (SBFM) Financial Statements

Compare
407 Followers

Sunshine Biopharma Financial Overview

Sunshine Biopharma's market cap is currently $6.56M. The company's EPS TTM is $-0.44; its P/E ratio is ―; Sunshine Biopharma is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 34.87M$ 24.09M$ 4.35M$ 228.43K$ 71.41K
Gross Profit$ 10.67M$ 8.34M$ 1.70M$ 110.60K$ 45.56K
Operating Income$ -5.81M$ -4.79M$ -8.67M$ -2.44M$ -576.87K
EBITDA$ -5.15M$ -3.82M$ -26.45M$ -12.09M$ -2.60M
Net Income$ -5.13M$ -4.51M$ -26.74M$ -12.77M$ -897.68K
Balance Sheet
Cash & Short-Term Investments$ 9.69M$ 16.29M$ 21.83M$ 2.05M$ 989.89K
Total Assets$ 30.56M$ 27.35M$ 29.24M$ 2.20M$ 1.05M
Total Debt$ 952.48K$ 657.71K$ 4.27M$ 1.90M$ 1.91M
Net Debt$ -8.73M$ -15.63M$ -17.55M$ -145.17K$ 923.23K
Total Liabilities$ 7.06M$ 6.14M$ 7.62M$ 1.99M$ 2.00M
Stockholders' Equity$ 23.50M$ 21.21M$ 21.63M$ 211.66K$ -954.84K
Cash Flow
Free Cash Flow$ -14.85M$ -9.56M$ -5.55M$ -1.83M$ -658.49K
Operating Cash Flow$ -12.53M$ -8.78M$ -5.25M$ -1.83M$ -657.30K
Investing Cash Flow$ -2.32M$ -656.15K$ -14.62M$ 0.00$ -1.19K
Financing Cash Flow$ 9.29M$ 3.43M$ 39.47M$ 2.90M$ 1.61M
Currency in USD

Sunshine Biopharma Earnings and Revenue History

Sunshine Biopharma Debt to Assets

Sunshine Biopharma Cash Flow

Sunshine Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis